| US 7,547,722 B2 | ||
| Chemical compounds | ||
| Kevin Michael Foote, Macclesfield (United Kingdom); Zbigniew Stanley Matusiak, Macclesfield (United Kingdom); Alexander Graham Dossetter, Macclesfield (United Kingdom); Jean Claude Arnould, Reims Cedex (France); Maryannick Andree Lamorlette, Reims Cedex (France); Benedicte Delouvrie, Reims Cedex (France); and Annie Hamon, Reims Cedex (France) | ||
| Assigned to AstraZeneca AB, Södertälje (Sweden) | ||
| Filed on May 22, 2007, as Appl. No. 11/752,007. | ||
| Application 11/380961 is a division of application No. 10/524978, granted, now 7,132,442, previously published as PCT/GB03/03631, filed on Aug. 19, 2003. | ||
| Application 11/752007 is a continuation of application No. 11/380961, filed on May 01, 2006, granted, now 7,268,158. | ||
| Claims priority of application No. 02292074 (EP), filed on Aug. 21, 2002. | ||
| Prior Publication US 2008/0045517 A1, Feb. 21, 2008 | ||
| Int. Cl. A61K 31/40 (2006.01); A61K 31/407 (2006.01); A61K 31/381 (2006.01); C07D 401/00 (2006.01); C07D 495/02 (2006.01); C07D 207/06 (2006.01) | ||
| U.S. Cl. 514—414 [514/338; 514/422; 514/423; 514/443; 546/276.7; 548/453; 548/530; 549/50] | 16 Claims |
1. A compound of Formula (I),
![]() R1 is selected from: hydrogen, optionally-substituted C1-6alkyl, optionally substituted C1-6alkanoyl, optionally substituted aryl or optionally-substituted arylC1-6alkyl;
R2 is an optionally-substituted mono or bi-cyclic aromatic ring;
R3 is selected from a group of Formula (IIf):
![]() R4 is selected from: hydrogen, optionally substituted C1-6alkyl, optionally substituted aryl, C1-3perfluoroalkyl, cyano, nitro, halo, R9O(CH2)m—, R9C(O)N(R10)—, R9R10NC(O)N(R10)(CH2)m—, R9S(On)(CH2)m— or R9R10NC(O)—(CR9R10)t(CH2)m—;
R5 is a group of Formula (III):
![]() R6 and R6a are independently selected from hydrogen, fluoro, optionally substituted C1-6alkyl, optionally-substituted aryl or optionally substituted arylC1-6alkyl, or R6 and R6a taken together and the carbon atom to which they are attached form a carbocyclic ring of 3-7 atoms, or R6 and R6a taken together and the carbon atom to which they are attached form a carbonyl group;
or when A is not a direct bond the group
![]() forms a carbocyclic ring of 3-7 carbon atoms or a heterocyclic ring containing one or more heteroatoms;
R9 and R10 are independently selected from: hydrogen, hydroxy, optionally substituted C1-6alkyl, optionally substituted aryl, optionally substituted arylC1-6alkyl, an optionally substituted carbocyclic ring of 3-7 atoms, optionally substituted heterocyclyl, optionally substituted
heterocyclylC1-6alkyl or R9 and R10 taken together can form an optionally substituted ring of 3-9 atoms or R9 and R10 taken together with the carbon atom to which they are attached form a carbonyl group;
R17 is independently selected from: hydrogen, hydroxy, cyano or optionally substituted C1-6alkyl;
R18 is a group of formula R18a—C(R9R10)0-1— wherein R18a is selected from: R19OC(O)—, R9R10NC(O)—, R9R10N—, R9C(O)—, R9C(O)N(R10)—, R9R10NC(O)—, R9R10NC(O)N(R10)—, R9SO2N(R10)—, R9R10NSO2N(R10)—, R9C(O)O—, R9OC(O)—, R9R10NC(O)O—, R9O—, R9S(On)—, R9R10NS(On)—, hydrogen, optionally substituted C1-6alkyl, optionally substituted heterocyclyl;
or R17 and R18 when taken together form an optionally substituted carbocyclic ring of 3-7 atoms or optionally substituted heterocyclyl;
R19 is selected from: hydrogen, optionally substituted C1-6alky, optionally substituted aryl, optionally substituted arylC1-6alkyl, optionally substituted C3-7cycloalkyl, optionally substituted heterocyclyl or optionally substituted heterocyclyl C1-6alkyl;
R21 and R22 are independently selected from hydrogen, optionally substituted C1-6alkyl, optionally substituted C3-7cycloalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylC1-6alkyl, optionally substituted C3-6alkenyl, optionally substituted C3-6alkynyl, —(C1-5alkyl)aa-S(On)—(C1-5alkyl)bb-; R9R10NC2-6alkyl, R9OC2-6alkyl or R9R10NC(O)C2-6alkyl, with the proviso that R9 and R10 independently or taken together are not optionally substituted aryl or optionally substituted arylC1-6alkyl; or
R21 and R22 taken together form an optionally substituted non-aromatic heterocyclic ring;
A is selected from:
a direct bond;
optionally-substituted C1-5alkylene wherein the optional substituents are independently selected from: optionally-substituted C1-6alkyl optionally-substituted aryl or optionally substituted arylC1-6alkyl;
a carbocyclic ring of 3-7 atoms;
a carbonyl group or —C(O)—C(RdRd)—, wherein Rd is independently selected from hydrogen and C1-2alkyl;
G is selected from: hydrogen, halo, CN, NO2, N, O, S(On),C(O), C(R9R10)t, optionally substituted C2-6alkenylene, optionally substituted C2-6alkynylene, optionally substituted heterocyclyl or a direct bond to R18,
m is an integer from 0 to 4;
n is an integer from 0 to 2;
t is an integer from 0 to 4;
aa and bb are independently selected from 0 or 1 with the proviso that
(i) when G is hydrogen, halo, CN or NO2 then R17 and R18 are both absent; and
(ii) when G is O, S(On), C(O) or C(R9R10)t then G is substituted by a single group independently selected from the definition of R17 or R18 and when G is a direct bond to R18 then G is substituted by a single group selected from R18;
or a salt or pro-drug thereof.
|